(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NEURORESTORE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

NEURORESTORE

ST13

US500000087948788

Class

42

Filing

87948788

Registration

6540155

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

42

Latest update

10/26/2021

Trademark type

Word

Nice classes

42

Filing date

06/05/2018

Registration date

10/26/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/26/2021

Last transaction

10/26/2021

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

First use anywhere

2020-11-00

First use in commerce

2020-11-00

Drawing code

4

Owner type

99

Owner location

HUDDINGE, SE

Examiner

HETZEL, DANNEAN

Law office

L60

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

AlzeCure Pharma AB

Representatives

Trevor P. Schmidt HUTCHISON PLLC

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Development of pharmaceutical substances for treatment and easement of Alzheimer's diseaseonly for human use; Scientific and technological servicesconducting early evaluations in the field of new pharmaceuticalspharmaceutical drug development servicespharmaceutical product evaluation and pharmaceutical research and development; scientific research and designscientific research in the field of pharmaceuticals; Research in relation to pharmaceuticals; Research and development of vaccines and medicines; Conducting early stage evaluations in the field of new pharmaceuticals; Pharmaceutical drug development services; Drug discovery services; Technical data analysis servicesdata analysis through data mining; Computer-supported technical analysis serviceschemical analysisdata analysis through data mining

Publications

History of USPTO decisions and trademark events.

42 publications found

R.PR

REGISTERED-PRINCIPAL REGISTER

10/26/2021

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

09/18/2021

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

09/17/2021

SUPC

STATEMENT OF USE PROCESSING COMPLETE

09/15/2021

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

09/15/2021

IUAF

USE AMENDMENT FILED

09/07/2021

EISU

TEAS STATEMENT OF USE RECEIVED

09/07/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/28/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/28/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/28/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/09/2021

EX1G

SOU EXTENSION 1 GRANTED

03/05/2021

EXT1

SOU EXTENSION 1 FILED

03/05/2021

EEXT

SOU TEAS EXTENSION RECEIVED

03/05/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

09/08/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/14/2020

PUBO

PUBLISHED FOR OPPOSITION

07/14/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/24/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/09/2020

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

04/27/2020

GNSL

LETTER OF SUSPENSION E-MAILED

04/27/2020

CNSL

SUSPENSION LETTER WRITTEN

04/27/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/07/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/07/2020

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

04/02/2020

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

10/02/2019

GNSI

INQUIRY TO SUSPENSION E-MAILED

10/02/2019

CNSI

SUSPENSION INQUIRY WRITTEN

10/02/2019

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

09/27/2019

ALIE

ASSIGNED TO LIE

09/24/2019

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

02/27/2019

GNSL

LETTER OF SUSPENSION E-MAILED

02/27/2019

CNSL

SUSPENSION LETTER WRITTEN

02/27/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/23/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/22/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/22/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/22/2018

GNRT

NON-FINAL ACTION E-MAILED

08/22/2018

CNRT

NON-FINAL ACTION WRITTEN

08/22/2018

DOCK

ASSIGNED TO EXAMINER

08/16/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

06/11/2018

NWAP

NEW APPLICATION ENTERED

06/08/2018

Continuous trademark protection

Get notified about every new filing that threatens NEURORESTORE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.